From Sunesis Waits Out Suspenseful Final Year of Pivotal Leukemia Trial:

Sunesis CEO Daniel Swisher
Sunesis CEO Daniel Swisher

Sunesis CEO Daniel Swisher. Photo courtesy of Sunesis Pharmaceuticals.